Excellent Presentations at JSCO2017

TOP > About JSCO > Awards > Excellent Presentations at JSCO2017

Followings are the Excellent Presentations selected by the Program Committee from those presented at the 55th Annual Meeting of the Japan Society of Clinical Oncology (JSCO2017).

 View abstracts: http://jsco.members-web.com/55award_eng/  

Number of presentations awarded the Excellent Presentations
48 (including 8 Best Presentations)

 

Head and neck cancer
  • BNCT for Head and Neck Cancer : The history of our institution
      Teruhito Aihara (University of Tsukuba)
Oral cancer
  • Investigation of new predictors for occult cervical lymph node metastasis in early-stage squamous cell carcinoma of the tongue 【Best Presentation】
      Nobuhiro Yamakawa (Nara Medical University) 
Breast cancer
  • Risk factors for febrile neutropenia in breast cancer patients receiving doxorubicin and cyclophosphamide chemotherapy
      Harumi Nakamori (University of Shizuoka)
  • The outcome of the recurrent breast cancer according to the tumor subtypes
      Eriko Tokunaga (Kyushu Cancer Center)
  • Analysis of body composition and application to nutrition counseling for breast cancer patients
      Keiko Ito (Hiroshima Prefectural Hospital)
  • Bevacizumab induces acute hypoxia and cancer progression in patients with refractory breast cancer: Multimodal functional imaging and multiplex cytokine analysis
      Shigeto Ueda (Saitama Medical University)
Hepato-biliary-pancreatic cancers
  • Identification of genes involved in resistance of anti-tumor drugs in induced cancer stem-like sphere cells 【Best Presentation】
      Ryouichi Tsunedomi (Yamaguchi University)
  • Cases of surgical resection for pancreatic neuroendocrine tumor
      Mariko Kamiya (Kanagawa Cancer Center)
  • The significance of Yap1-Mob1 dysregulation in human primary liver cancer
      Keishi Sugimachi (National Kyushu Cancer Center / Kyushu University Beppu Hospital)
  • Strategy of postoperative surveillance after IPMN resection based on the risk factors for the development of metachronous lesions in the remnant pancreas
      Tatsuo Hata (Tohoku University)
Esophageal cancer
  • Effect of perioperative oral care on prevention of postoperative pneumonia associated with esophageal cancer surgery: A multicenter case-control study with propensity score matching analysis 【Best Presentation】
      Soutome Sakiko (Nagasaki University Hospital)
  • Influence of anti-inflammatory effect due to postoperative ghrelin administration after radical esophagactomy on prognosis of patients with esophageal cancer
      Yasuhiro Miyazaki (Osaka University)
  • Prevention of atrial fibrillation using landiolol hydrochloride after esophagectomy for esophageal cancer: A randomized, double-blind, placebo-controlled trial
      Toshiyasu Ojima (Wakayama Medical University)
  • Surgical outcome of elderly patients over 75 years old with esophageal cancer
      Norio Yukawa (Yokohama City University)
  • Impact of visceral obesity on clinicopathological characteristics in patients with esophageal squamous cell carcinoma
      Akihiko Okamura (The Cancer Institute Hospital of JFCR)
  • Efficacy of postoperative adjuvant cancer peptide vaccine for pN(+) thoracic esophageal SCC patients and its association with tumor microenvironment
      Takushi Yasuda (Kindai University)
Gastric cancer
  • Multicenter phase II study of trastuzumab in combination with S-1 and docetaxel for HER2-positive advanced gastric cancer 【Best Presentation】
      Shunsuke Kagawa (Okayama University)
  • A randomized phase III trial comparing 4 courses and 8 courses of S-1 adjuvant chemotherapy for p-stage II gastric cancer: JCOG1104 (OPAS-1)
      Manabu Ohashi (Cancer Institute Hospital)
  • Postoperative weight loss leads to a poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer
      Toru Aoyama (Kanagawa Cancer Center / Yokohama City University)
  • Effect of exosomes from scirrhous gastric carcinoma on the histologic findings of peritoneal tissue
      Tomohisa Okuno (Osaka City University)
  • A biomarker analysis to predict the outcomes of patients with gastric cancer who received neoadjuvant chemotherapy. An Exploratory study of the randomized phase II COMPASS trial
      Takashi Oshima (Yokohama City University)
  • A multicenter cohort study of combination therapy with trastuzumab for HER2-positive advanced gastric cancer (KSCC1105)
      Masaaki Iwatsuki (Kumamoto University)
  • A phase II study of nab-paclitaxel in combination with ramucirumab in patients with unresectable advanced/recurrent gastric cancer refractory to first-line chemotherapy containing fluoropyrimidines
      Hideki Shimodaira (Tohoku University Hospital)
Colorectal cancer
  • Expression profile of microRNA as a prognostic biomarker in patients with stage II colorectal cancer 【Best Presentation】
      Hiroki Ochiai (National Cancer Center Hospital)
  • Phase II study of FOLFOXIRI plus bevacizumab for metastatic colorectal cancer: QUATTRO study
      Kentaro Yamazaki (Shizuoka Cancer Center)
  • Clip-test Ver. 2, a novel and simple tool for monitoring the growth of oxaliplatin induced peripheral neuropathy
      Tadashi Onishi (NTT Osaka Hospital)
  • Clinical impact of molecular positive lymph node status by OSNATM assay in colorectal cancer: A Prospective Multicenter Trial in Japan
      Tomohisa Furuhata (St. Marianna University Toyoko Hospital)
  • RAS, BRAF and MSI status as a biomarker for adjuvant therapy after the curative resection of colorectal cancer
      Hideaki Miyauchi (Chiba University)
  • Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine in patients with stage III colorectal cancer: Updated results of Japan Clinical Oncology Group study (JCOG0910)
      Nobuhiro Takiguchi (Chiba Cancer Center)
  • A Retrospective Cohort Study Evaluating the Safety and Efficacy of Regorafenib in Patients with Metastatic Colorectal Cancer[HGCSG1401] : Analysis of tumor location
      Kazuteru Hatanaka (Hakodate Municipal Hospital)
  • A Retrospective Cohort Study Evaluating the Safety and Efficacy of TAS-102 in Patients with Metastatic Colorectal Cancer [HGCSG1503]
      Satoshi Yuki (Hokkaido University Hospital)
  • Analysis of postoperative respiratory function after laparoscopic colorectal surgery in COPD patients
      Naoyuki Toyota (Keio University)
Gynecologic cancers
  • Efficacy of HPV vaccination against HPV infection in Japanese young women【Best Presentation】
      Risa Kudo (Niigata University)
  • Statin induced tumor suppressor genes to sensitize cisplatin-resistant cells
      Chiho Koi (University of Occupational and Environmental Health)
  • Establishment and characterization of patient-derived xenografts of clear cell carcinoma of the ovary
      Hiroshi Asano (Hokkaido University Hospital)
  • Analysis of association of the number of board-certified gynecologic oncologist and 5-year survival ratio of cervical cancer patients in each hospital
      A Yagi (Osaka University)
Prostate and testicular cancers
  • Serum testosterone level is a useful biomarker to aid optimal treatment selection in men with castration-resistant prostate cancer
      Kohei Hashimoto (Sapporo Medical University)
  • Long-term clinical outcome of whole pelvis irradiation for patients with very high-risk locally advanced prostate cancer using simultaneous integrated boost intensity-modulated radiation therapy
      Kenji Takayama (Kyoto University)
  • The Impact of Tertiary Gleason Pattern 5 in 2014 ISUP/WHO New Grading System on Recurrence Following Radical Prostatectomy in Patients with Prostate Cancer
      Masashi Kato (Nagoya University)
Renal and urothelial cancers
  • Risk factors for recurrence after operation in patients with pT1a renal cell carcinoma -Sub analysis of the multi-institutional national database of the Japanese Urological Association【Best Presentation】
      Nobuyuki Nakajima (Japanese Urological  Association / Tokai University)
  • Mitochondrial ND1 mutations were associated with postoperative prognosis of localized renal cell carcinoma
      Hakushi Kim (Tokai University School of Medicine Department of Urology)
  • Developing a novel diagnostic model for bone metastases in renal cell carcinoma patients using computer-assisted diagnosis system for bone scans and bone turnover markers
      Takeshi Ujike (Department of Urology, Osaka University Graduate School of Medicine)
  • FDG PET/CT as a prognostic biomarker for the patients with advanced renal cell carcinoma after first molecular targeted therapy
      Noboru Nakaigawa (Yokohama City University Graduate School of Medicine)
Sarcomas of the soft tissues and bone
  • Analyzing multiple risk factors in patients with bone and soft tissue sarcoma : A case-control study
      Y Araki (Kanazawa University / National Cancer Center Hospital)
  • New challenges in the clinical development of drugs for rare cancers -Investigator Initiated Trials for rare cancers-
      Tadaaki Nishikawa (National Cancer Center Hospital / Saitama Medical University)
Family cancer syndromes
  • High precision assay system of BRCA1/2 variants and copy number alterations by next generation sequencing analysis
      Yosuke Hirotsu (Yamanashi Central Hospital)
Lymph node metastasis
  • Creation of a lung metastasis activation mouse model by dissection of tumor-bearing lymph nodes【Best Presentation】
      Sachiko Horie (Tohoku University)
Patient advocacy
  • Cancer families’ concerns and information support from the questionnaire survey of cancer patients’ view
      Masayo Hayakawa (National Cancer Center)

  

Past Presentation Awards